Emerging concepts, hot topics, and open questions in today’s pancreatic cancer research
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-09 · 1881 (4) · 189614
DOI: 10.1016/j.bbcan.2026.189614 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-09. Verfasst von Corinna Keber und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, UKGM Marburg, 35043 Marburg, Germany; Clinical Research Unit 325 (CRU325), Germany. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 270 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Despite intense research, pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies to date. The low 5-year survival rate of currently 8-10% has only marginally improved over the last years, necessitating novel approaches and a thinking "outside the box". We as translational basic and medical scientists working in a clinical research unit on tumor-stroma interactions in PDAC (the DFG-funded CRU325) have sought to identify emerging concepts in current pancreatic cancer research. We have addressed recent developments and open questions, covering a wide spectrum of topics, including clinical treatment, lifestyle, the tumor microenvironment, drug targeting, vaccination, and the microbiome. This selection of topics is highly personal and does not claim to be complete, yet it represents those areas that we believe may contribute to relevant developments in the near future. In our review, we not only briefly describe the state of the art but also pinpoint the potential of recent advances, while not ignoring current contradictions or uncertainties. Taken together, we provide our subjective view on upcoming topics in today's PDAC research landscape.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Pathology, UKGM Marburg, 35043 Marburg, Germany; Clinical Research Unit 325 (CRU325), Germany.
- Institute of Pharmacology, Marburg University, 35043 Marburg, Germany; Clinical Research Unit 325 (CRU325), Germany.
- Institute for Medical Microbiology and Hygiene, Marburg University, 35043 Marburg, Germany; Clinical Research Unit 325 (CRU325), Germany.
- Institute of Systems Immunology, Center for Tumor and Immune Biology, Marburg University, 35043 Marburg, Germany; Clinical Research Unit 325 (CRU325), Germany.
- Institute for Tumor Immunology, Center for Tumor and Immune Biology, Marburg University, 35043 Marburg, Germany; Clinical Research Unit 325 (CRU325), Germany.
- Department of Neurosurgery, Marburg University, UKGM Marburg, 35043 Marburg, Germany; Clinical Research Unit 325 (CRU325), Germany.
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Keber, C., Schmitt, M., Visekruna, A., Brichkina, A., von Strandmann, E. P., Bartsch, J. W., Huber, M., Bauer, U. M., Gress, T. M., & Lauth, M. (2026). Emerging concepts, hot topics, and open questions in today’s pancreatic cancer research. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(4), 189614. https://doi.org/10.1016/j.bbcan.2026.189614
Vancouver
Keber C, Schmitt M, Visekruna A, Brichkina A, von Strandmann EP, Bartsch JW, et al. Emerging concepts, hot topics, and open questions in today’s pancreatic cancer research. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(4):189614. doi:10.1016/j.bbcan.2026.189614
BibTeX
@article{Keber2026,
author = {Keber, Corinna and Schmitt, Mark and Visekruna, Alexander and Brichkina, Anna and von Strandmann, Elke Pogge and Bartsch, Jörg W and Huber, Magdalena and Bauer, Uta-Maria and Gress, Thomas M and Lauth, Matthias},
title = {Emerging concepts, hot topics, and open questions in today’s pancreatic cancer research},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
volume = {1881},
number = {4},
pages = {189614},
doi = {10.1016/j.bbcan.2026.189614}
}
EUVIMED